Perimenopause and cholesterol: what actually changes
If your cholesterol panel looks different than it did a few years ago and nothing about your diet has changed, perimenopause is a legitimate explanation rather than a dodge.
The mechanism
Sex steroids have wide effects on cardiovascular risk factors, and losing them changes your lipids in a specific, predictable direction. As ovarian hormones decline through the transition, LDL cholesterol and triglycerides rise while HDL cholesterol falls. Coronary heart disease has a low incidence in premenopausal women, and menopause itself acts as an additional risk factor rather than just more birthdays.
Estrogen isn't the whole story, either. FSH climbs sharply during this window, and research found FSH levels correlate with total cholesterol even after adjusting for estrogen — the same work reported that high cholesterol is significantly more common in perimenopausal than premenopausal women. So: a hormonal transition, not a failure of discipline.
What's actually worth tracking
Total cholesterol drifting up is the least useful number to fixate on. More informative:
- LDL cholesterol: the main driver of the rise, and the number most tied to cardiovascular risk over time
- HDL cholesterol: worth watching precisely because this is the one that tends to fall
- Triglycerides: more responsive to alcohol, refined carbohydrate and insulin sensitivity than to hormones directly, but they move in this window too
What to actually do
This is not a signal that a heart attack is imminent. It's a signal that your cardiovascular risk profile deserves the same attention in your forties that it gets automatically in your sixties.
Ask for a full lipid panel rather than a total-cholesterol number, and ask when the next one should be. Fiber, omega-3 intake and resistance training all still work here — they just have more to push against than they did five years ago.
One honest caveat: a shift that's purely hormonal and a shift that needs treatment can look identical on paper. That's what the follow-up panel and a real conversation with your provider are for. Ask for the repeat far enough out to mean something — a single panel taken mid-transition is a snapshot, and the trend across two or three is the part that actually informs a decision.
